Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge Advises SJ (Statens Järnvägar) on Purchase of Trains for a Value of SEK 2 billion
Mandate

Vinge Advises SJ (Statens Järnvägar) on Purchase of Trains for a Value of SEK 2 billion

May 22, 2008

SJ has reached an agreement together with Bombardier to purchase the most recent version of the Regina train, fast multiple-unit trains purposed for long-distance connections. The X2000-train will be replaced with the Regina train on a number of connections. The newly purchased Regina trains will be put in operation 2010 and are meant to operate routes between Stockholm and Värmland, Dalarna, Småland, and Trestadsregionen as well as Västkustbanan (Gothenburg – Malmö). The first delivery of the Regina train will consist of 20 trains for an approximate value of SEK 2 billion.

Vinge’s team was made up of partner Björn Gustavsson, assisted by Mikael Satama Granberg.    

 

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

 Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

 Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

 Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026